Use of Remdesivir to Treat COVID-19 after Orthotopic Heart Transplant

PURPOSE: Guidance for managing orthotopic heart transplant (OHT) recipients with COVID-19 infection is limited. There have been 80 published cases of OHT recipients with COVID-19 infection to date, and they show a higher incidence of infection and greater mortality (26-41%) than that observed in the...

Descripción completa

Detalles Bibliográficos
Autores principales: Duran, J.M., Lin, A.Y., Barat, M., Aslam, S., Adler, E.D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Inc. 2021
Materias:
(22)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7979417/
http://dx.doi.org/10.1016/j.healun.2021.01.1786

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7979417/
http://dx.doi.org/10.1016/j.healun.2021.01.1786

Ejemplares similares